Closing the loop for brain imaging in depression

June 5, 2018 by David Mehler, Plos Blogs, Public Library of Science
Credit: CC0 Public Domain

Depression can have a profound impact on affected individuals and those around them. It is one of the most common mental health conditions, and its symptoms include sustained feeling of sadness, hopelessness, and guilt. In severe cases, these symptoms may be aggravated by suicidal thoughts, or even attempts. The odds of experiencing a depressive episode are relatively high: at least one in six individuals will experience an episode in their lifetime.

Although the term depression suggests that it represents a single psychiatric condition, patients vary tremendously in their symptoms, risk factors, and response to available treatment. Risk factors include not only genetic variations and hormonal changes, but also destructive thinking patterns, or stressful and traumatising experiences. Current treatments primarily include medication and psychotherapy. Medication prescribed in depression targets different brain chemical systems, involving neurotransmitters that include serotonin and dopamine. These are involved in communication between nerve cells and, more generally, in the feeling of well-being. Psychotherapy aims to help patients develop effective coping strategies to use when they are faced with challenges and setbacks. Most depressed individuals will eventually recover – however, up to one third may not.

One branch of depression research focuses on finding biomarkers that can identify individuals that will most likely benefit from a specific therapy. The field also works on developing innovative treatments. However, both goals require a better understanding of the underlying biology. Brain imaging research, clinical psychology, and genetics have provided some fascinating answers, but have also posed new challenging questions.

We asked three experts and pioneers in depression research: How do you study clinical depression, what role does brain imaging play in your research, and what challenges lie ahead for the field?

Ian H. Gotlib (Professor of Psychology, Department of Psychology, Stanford University):

"Over the past two decades, we have learned that depression is a heterogeneous disorder, with wide variations in symptom presentation, age of onset, number and duration of episodes, and causal factors. In my lab, we take this heterogeneity seriously – we administer structured diagnostic interviews to every participant in our studies. And perhaps more important, we conduct multimodal assessments of depression – we examine , function, and connectivity; endocrine function, both under acute stress and throughout the day; cognitive functioning, including biases in attention, interpretation, and memory; and digital phenotyping of depressed children, adolescents, and adults.

The number of brain imaging studies has grown exponentially, and there is now a burgeoning literature examining brain structure, function, and connectivity in depressed individuals. Neuroimaging studies have helped to elucidate the neural circuitry involved in reward processing and the processing of emotional experiences. Because the two cardinal symptoms of depression in the Diagnostic and Statistical Manual (DSM) involve the persistent experience of negative affect and anhedonia, researchers studying depression have focused on examining their neural underpinnings. From these investigations we are learning about anomalous neural characteristics of depressed individuals that may be related to difficulties in daily functioning and that may serve as intervention targets. We know far less, however, about aspects of brain structure, function, and connectivity that place individuals at risk for developing depression, that keep high-risk persons from experiencing depression, and that influence the maintenance of and recovery from this disorder. We also know relatively little about the developmental trajectories of these anomalous neural characteristics, knowledge that is critical in understanding differences between children and adults in the presentation of depression."

Helen Mayberg (Professor of Neurology, Neurosurgery, Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai):

"Our lab takes a circuit approach to the study of : Studies integrate multimodal neuroimaging strategies and quantitative behavioral and psychophysiological metrics within experimental clinical trial protocols to define brain mechanisms that mediated anti–depressant treatments. The overarching goal is to develop imaging biomarkers and algorithms that will identify patient subgroups and optimize treatments for individual patients. This work also serves as a basis for ongoing testing and refinement of deep brain stimulation (DBS) of the subcallosal cingulate, a technique that our lab is investigating for .

Imaging has provided new perspectives on understanding the pathogenesis of depression, as well as treatment mechanisms. Studies have systematically defined a core set of consistent regional abnormalities, correlations between symptoms and abnormal function of specific brain regions, and evidence of putative depression subtypes. Multimodal imaging and advanced analytic methods have further provided strategies to build depression circuit models that directly test treatment selection biomarkers.

The challenge for the 'field' will be to define what method(s) are 'good enough' to warrant meaningful replication studies of an encouraging finding. Balancing a useful clinical biomarker that might improve treatment selection or response assessment from those addressing fundamental mechanisms of circuit dysfunction and pathophysiology require different strategies and standards."

David EJ Linden (Professor of Translational Neuroscience, Cardiff University and Maastricht University):

"One of the main research techniques used in my group is real-time functional magnetic resonance imaging (fMRI) neurofeedback training. fMRI allows researchers to trace activation patterns that are associated with external stimuli or internal mental states in real time, and we can feed these activation changes back to patients, so they can learn to regulate them themselves. This opens up interesting potential therapeutic avenues, for example, for emotion regulation training in depression, but also other mental disorders.

Functional brain mapping with fMRI has provided crucial new insights in the neural representations of affect and its disturbances. It has become clear that there are strong links between classical emotion and motivation areas, implemented through functional anatomical links between the limbic system and the basal ganglia, for example, in the ventral striatum. This has sparked renewed interest in the role of reward mechanisms in depression. A future challenge will be to work on the standardisation of imaging protocols across sites and conduct formal studies of the potential diagnostic and predictive value of these functional imaging patterns in order to produce clinically useful biomarkers."

Researchers and clinicians agree that depression can manifest differently in each individual. Neuroimaging and multimodal studies allow investigators to examine underlying mechanisms of such variability, although identifying robust biomarkers remains challenging. This knowledge informs translational research into new circuit-based interventions, including clinical trials of DBS and neurofeedback treatment. Thereby, the field may "close the loop," yielding more effective and individually tailored treatments for .

Explore further: New method to identify causal mechanisms in depression

Related Stories

New method to identify causal mechanisms in depression

December 6, 2017
People with major depressive disorder have alterations in the activity and connectivity of brain systems underlying reward and memory, according to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. ...

Cognitive training reduces depression, rebuilds injured brain structure and connectivity after traumatic brain injury

May 30, 2018
New research from the Center for BrainHealth at The University of Texas at Dallas shows that certain cognitive training exercises can help reduce depression and improve brain health in individuals years after they have suffered ...

Neuroimaging categorizes four depression subtypes

December 6, 2016
Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.

Emotion-processing networks disrupted in sufferers of depression

January 20, 2016
Regions of the brain that normally work together to process emotion become decoupled in people who experience multiple episodes of depression, neuroscientists report. The findings may help identify which patients will benefit ...

Brain scans may help clinicians choose talk therapy or medication treatment for depression

March 24, 2017
Researchers from Emory University have found that specific patterns of activity on brain scans may help clinicians identify whether psychotherapy or antidepressant medication is more likely to help individual patients recover ...

New data on brain network activity can help in understanding 'cognitive vulnerability' to depression

May 9, 2016
Neuroimaging studies of interconnected brain networks may provide the "missing links" between behavioral and biological models of cognitive vulnerability to depression, according to a research review in the Harvard Review ...

Recommended for you

It's okay when you're not okay: Study re-evaluates resilience in adults

August 16, 2018
Adversity is part of life: Loved ones die. Soldiers deploy to war. Patients receive terminal diagnoses.

Expecting to learn: Language acquisition in toddlers improved by predictable situations

August 16, 2018
The first few years of a child's life are crucial for learning language, and though scientists know the "when," the "how" is still up for debate. The sheer number of words a child hears is important; that number predicts ...

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

Stress during pregnancy increases risk of mood disorders for female offspring

August 16, 2018
High maternal levels of the stress hormone cortisol during pregnancy increase anxious and depressive-like behaviors in female offspring at the age of 2, reports a new study in Biological Psychiatry. The effect of elevated ...

Letting PTSD patients choose method of treatment improves their health, quality of life: new research

August 16, 2018
Letting people with post-traumatic stress disorder (PTSD) choose between treatment methods improves their quality of life and reduces the disorder's symptoms, according to new research from Case Western Reserve University.

Dominant men make decisions faster

August 16, 2018
Hierarchies exist across all human and animal societies, organized by what behavioral scientists refer to as dominance. Dominant individuals tend to climb higher up the hierarchy ladder of their particular society, earning ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.